Jazz Pharmaceuticals plc’s (JAZZ) share price has entered into oversold territory with a stochastic value of 18.3129. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 12 cents over the past month to $4.41 per share. Jazz Pharmaceuticals plc is a Zacks #2 Rank (“Buy”) company.
JAZZ PHARMACEUT (JAZZ): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment